Back to List

Assoc. Prof. David W Ellis




Dermatopathology, Histopathology

Special interests

Haematopathology, dermatopathology and general surgical pathology


Mile End


Associate Professor David Ellis is a graduate of the University of Melbourne and trained as a pathologist at Royal Prince Alfred Hospital, Sydney. He has been a senior consultant histopathologist at the Royal Melbourne, St Vincent's and the Peter MacCallum Hospitals in Melbourne, and a full-time consultant with Melbourne Pathology. In Adelaide since 1994, A/Prof Ellis has been in private practice with Gramps Skin Pathology, Gribbles Pathology and Clinpath Laboratories, where he was Medical Director until 2000. He has also been a part-time consultant at the Flinders Medical Centre and Royal Adelaide and Queen Elizabeth Hospitals, as well as Associate Professor at Flinders University since 2007.

As a national leader in lymphoma diagnosis, A/Prof Ellis was the pathology convenor for the Australasian Leukaemia Lymphoma Group from 1992 and has been an invited speaker to national meetings of medical oncologists, haematologists and pathologists throughout Australasia for many years. 

He has been actively involved with the Royal College of Pathologists of Australasia through the Anatomical Pathology Advisory Committee, as founding Chair of the Cancer Services Advisory Committee and as a member of the Informatics Advisory Committee.

He is past President of the Australasian Division of the International Academy of Pathology (IAP), and currently represents Australasia on the IAP International Executive Committee.

Since co-chairing the Australian Cancer Network Clinical Practice Guidelines for the Diagnosis and Management of Lymphoma in 2005, A/Prof David W Ellis has led the introduction of structured pathology reporting for cancer into Australasia, first as the inaugural chair of the National Structured Pathology Reporting for Cancer Project under the RCPA, Cancer Australia and Cancer Institute NSW, and now as Executive Officer (Immediate Past President) of the International Collaboration on Cancer Reporting (ICCR), which he also represents on the UICC TNM Staging Committee in Geneva.

He represents the RCPA as inbound liaison to the Cancer Committee of the College of American Pathologists (CAP), USA.

David held the position of CEO of Clinpath from February 2015 before handing over to Dr Fergus Whitehead late in 2016.  He is currently working part time and maintaining an active interest in haematopathology and dermatopathology.